Skip to content

Site logo

Main menu
  • Company
    • Company overview
    • Stories
    • History
    • Environmental, Social & Governance (ESG)
      • ESG overview
      • Philanthropy
      • Merck Medical Outreach Program
      • Impact investing
      • Transparency disclosures
      • ESG resources
    • Leadership
      • Leadership overview
      • Board of directors
      • Executive team
    • Culture & values
      • Culture & values overview
      • Code of conduct & compliance
    • Diversity & inclusion
    • Policies & positions
    • Business development & licensing
    • Suppliers
      • Suppliers overview
      • Supplier registration
      • Supplier help for Ariba
  • Research
    • Research overview
    • Areas of focus
      • Oncology
      • Vaccines
      • Infectious diseases
      • Cardio-metabolic disorders
    • Pipeline
    • Discovery & development
    • R&D locations
    • Clinical trials
      • Clinical trials overview
      • Find a trial
      • Diversity in clinical trials
  • Products
    • Products list
    • Safety data sheets
    • Product patents
    • Merck authorized distributors
  • Patients
    • Patients overview
    • Patient support programs
    • Patient resources
    • Patient & treatment education
  • Careers
    • Careers
    • Search jobs
    • Our divisions
      • Research & development
      • Manufacturing & supply
      • Human Health
      • Animal Health
      • Global support functions
    • Veterans
    • Student opportunities
    • Compensation & benefits
    • How we hire
    • MSD Careers
    • Events
    • Talent community
  • Investors
    • Investors overview
    • Events & presentations
    • Financial information
      • Financial information overview
      • SEC filings
    • Stock information
    • Investor resources
      • Investor resources overview
      • Organon resources
      • Request for information
  • Media
    • Media overview
    • News releases
    • Company statements
    • Media library & contacts
    • Company fact sheet
two scientists wearing masks

Our COVID-19 efforts

Learn more
Contact us

Worldwide Countries outside of the United States and Canada.

What can we help you find?

Search for:
Environmental, Social & Governance

Our commitment to the Black community

From clinical trials to jobs creation, here’s how we’re advancing health equity, employment and more within the Black community

February 9, 2021

Share this article

A Merck scientist working in the lab

True innovation is achieved through powerful ideas from a diverse range of backgrounds. At our company, amplifying inclusion and promoting diversity have always been essential to our success.

“Our goal is to create an equitable environment in which all people have a fair opportunity to advance their careers,” says Ken Frazier, our company’s chairman. To achieve that, we’ve empowered our leaders and managers to foster a more diverse workforce and to drive equity across our organization and beyond.

Here are just a few ways we are working to engage with the Black community both within our company and in the community at large:

01.

Prioritizing diversity in our clinical trials

A woman at the doctors office having a conversation

Our responsibility as a company is clear: We must advance knowledge about the safety and efficacy of treatments in all people. And for us, this starts with ensuring the representation of diverse populations from the very beginning of medicine and vaccine development – our clinical trials.

Our U.S. clinical trials team has adopted an approach that puts patients front and center. From trial design to recruitment to all the way through implementation, patients drive our process.

“Diversity in our trials is not just an initiative – it’s our way of working,” says Adrelia Allen, director, clinical trial patient diversity. “It’s woven into all steps of the trial process, and it must be proactive – not reactive.”

Read more about Clinical trials & the power of diversity

02.

Making commitments to increase employment

A man walking through the workplace

In this moment when all Americans share an aspiration for economic opportunity, leading executives and employers across industries are taking action to make meaningful, measurable and lasting systemic impact on racial and economic justice and to create a more equitable society.

That’s why Ken Frazier has signed on as co-chair for OneTen, an initiative aimed at closing the opportunity gap for Black Americans. OneTen will combine the power of American companies to upskill, hire and promote one million Black Americans over the next 10 years into family-sustaining jobs with opportunities for advancement.

“We are very excited to be participating in this collaboration and proud that our CEO is one of the drivers behind this initiative,” says Steve Mizell, EVP and chief human resources officer. “We look forward to learning, sharing and growing across the network of organizations who will be joining in these efforts.”

03.

Closing the opportunity gap

High school students at our Kenilworth site in June 2019 as part of the INROADS program

Our mission of saving and improving lives goes beyond the important work we do creating medicines and vaccines. It also extends to our impact on the community, and in fulfilling that mission, we can also help efforts to close the opportunity gap.

That’s why our company is a corporate partner with Year Up, an organization committed to ensuring equitable access to economic opportunity, education and justice for all young adults—no matter their background, income or zip code. Through a combination of in-demand technical and professional skills development and corporate internship experience, Year Up’s intensive training program connects talented and motivated young adults to meaningful career pathways, while connecting companies like Merck to a pipeline of diverse, bright and skilled talent.

In 2019, Merck partnered with INROADS, an international nonprofit organization that prepares talented, diverse youth for corporate and community leadership, and launched a yearlong College Links program for high school students in Newark, New Jersey, to increase college and career readiness.

Although there’s more work to be done, these are just some of the ways our company is living its commitment to stand up for the Black community and foster a more diverse and prosperous world.

Discover more stories

Pride, pediatrics and parenting

New podcast: Meet the dealmakers 

Safeguarding the environment through green chemistry

View all stories

Explore more in

Collaboration
Corporate responsibility
Diversity and inclusion

Related links

related content image #1

Diversity & inclusion

Our workforce represents the people we serve

related content image #2

Our culture and values

It all comes back to saving and improving lives

related content image #3

Environmental, Social & Governance (ESG)

Supporting society, people and communities around the world is fundamental to our long-term success

Connect with us on social

social icon social icon social icon social icon social icon
  • MerckHelps
    Merck Patient Assistance Program provides certain Merck medicines and adult vaccines for free to qualified patients
  • Merck Access Program
    Information about insurance coverage and financial assistance options for eligible patients
  • Clinical trials
    Learn about our clinical trials and find available studies
  • Merck Manuals
    Medical information source covering thousands of topics in all fields of medicine
  • Environmental, Social & Governance (ESG) Report
    Reporting on our commitment to operating responsibly to benefit society
  • Merck for Mothers
    An initiative to create a world where no woman has to die giving life
  • Merck Animal Health
    The global animal health business unit of Merck
  • Health Plan - Transparency in Coverage
    In compliance with the Consolidated Appropriations Act, learn more about our health plan's pricing information.
  • Forward-looking statement
  • Cookie policy
  • Privacy
  • Transparency disclosure
  • Terms of use
  • Accessibility
  • Sitemap
Copyright © 2023 Merck & Co., Inc., Rahway, NJ USA, and its affiliates. All rights reserved. | This site is intended only for residents of the United States and Canada.
Accessibility icon View Privacy Shield Verification Status View APEC CBPR Privacy Certification Status

Forward-looking statement of Merck & Co., Inc., Rahway, N.J., USA

This website of Merck & Co., Inc., Rahway, N.J., USA (the “company”) includes “forward-looking statements” within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995. These statements are based upon the current beliefs and expectations of the company’s management and are subject to significant risks and uncertainties. There can be no guarantees with respect to pipeline candidates that the candidates will receive the necessary regulatory approvals or that they will prove to be commercially successful. If underlying assumptions prove inaccurate or risks or uncertainties materialize, actual results may differ materially from those set forth in the forward-looking statements.

Risks and uncertainties include but are not limited to, general industry conditions and competition; general economic factors, including interest rate and currency exchange rate fluctuations; the impact of the global outbreak of novel coronavirus disease (COVID-19); the impact of pharmaceutical industry regulation and health care legislation in the United States and internationally; global trends toward health care cost containment; technological advances, new products and patents attained by competitors; challenges inherent in new product development, including obtaining regulatory approval; the company’s ability to accurately predict future market conditions; manufacturing difficulties or delays; financial instability of international economies and sovereign risk; dependence on the effectiveness of the company’s patents and other protections for innovative products; and the exposure to litigation, including patent litigation, and/or regulatory actions.

The company undertakes no obligation to publicly update any forward-looking statement, whether as a result of new information, future events or otherwise. Additional factors that could cause results to differ materially from those described in the forward-looking statements can be found in the company’s Annual Report on Form 10-K for the year ended December 31, 2022 and the company’s other filings with the Securities and Exchange Commission (SEC) available at the SEC’s Internet site (www.sec.gov).

No Duty to Update
The information contained in this website was current as of the date presented. The company assumes no duty to update the information to reflect subsequent developments. Consequently, the company will not update the information contained in the website and investors should not rely upon the information as current or accurate after the presentation date.

Decline Accept

You are leaving Merck.com

Continue

Welcome to Merck.com

By continuing, you will be directed to a site intended only for residents of the United States and Canada. We are called MSD everywhere, except in the United States and Canada where we are known as Merck & Co Inc, Rahway, NJ USA.

Continue